(ONTO) Onto Innovation - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6833441057
Stock: Optical Metrology, Inspection Systems, Process Control, Analytical Software
Total Rating 58
Risk 88
Buy Signal -0.25
| Risk 5d forecast | |
|---|---|
| Volatility | 62.7% |
| Relative Tail Risk | -6.85% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.93 |
| Alpha | 14.63 |
| Character TTM | |
|---|---|
| Beta | 2.078 |
| Beta Downside | 0.664 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.82% |
| CAGR/Max DD | 0.51 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
choppy
Description: ONTO Onto Innovation March 05, 2026
Onto Innovation Inc. (ONTO) designs, develops, and manufactures process control tools. Their offerings include optical metrology and inspection systems, lithography systems, and analytical software.
The company provides solutions for process and yield management, device packaging, and testing. These solutions are delivered via standalone systems for optical metrology, macro-defect inspection, packaging lithography, and thin film measurements. The semiconductor equipment sector is highly cyclical, driven by capital expenditure trends in chip manufacturing.
ONTOs product applications span semiconductor and advanced packaging, silicon wafers, LEDs, VCSELs, MEMS, CMOS image sensors, power devices, analog devices, RF filters, and data storage. Their business model includes revenue from systems, software, spare parts, and services, including software licensing.
To further understand ONTOs competitive landscape and financial performance, consider exploring its detailed profile on ValueRay.
Headlines to watch out for
- Semiconductor capital expenditure directly impacts equipment demand
- Advanced packaging adoption drives metrology and inspection tool sales
- Global economic slowdown reduces chip manufacturing investment
- Competition intensifies in process control equipment market
- Supply chain disruptions affect manufacturing and delivery schedules
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 136.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 2.56 > 1.0 |
| NWC/Revenue: 104.4% < 20% (prev 132.4%; Δ -28.06% < -1%) |
| CFO/TA 0.14 > 3% & CFO 328.3m > Net Income 136.8m |
| Net Debt (-625.6m) to EBITDA (220.4m): -2.84 < 3 |
| Current Ratio: 5.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (49.5m) vs 12m ago -0.18% < -2% |
| Gross Margin: 49.72% > 18% (prev 0.52%; Δ 4.92k% > 0.5%) |
| Asset Turnover: 44.83% > 50% (prev 46.64%; Δ -1.81% > 0%) |
| Interest Coverage Ratio: -15.63 > 6 (EBITDA TTM 220.4m / Interest Expense TTM -9.79m) |
Altman Z'' 7.31
| A: 0.44 (Total Current Assets 1.27b - Total Current Liabilities 218.9m) / Total Assets 2.37b |
| B: 0.31 (Retained Earnings 743.8m / Total Assets 2.37b) |
| C: 0.07 (EBIT TTM 153.1m / Avg Total Assets 2.24b) |
| D: 2.78 (Book Value of Equity 743.8m / Total Liabilities 267.1m) |
| Altman-Z'' Score: 7.31 = AAA |
Beneish M -2.73
| DSRI: 0.86 (Receivables 268.9m/308.1m, Revenue 1.01b/987.3m) |
| GMI: 1.05 (GM 49.72% / 52.19%) |
| AQI: 1.73 (AQ_t 0.41 / AQ_t-1 0.24) |
| SGI: 1.02 (Revenue 1.01b / 987.3m) |
| TATA: -0.08 (NI 136.8m - CFO 328.3m) / TA 2.37b) |
| Beneish M-Score: -2.73 (Cap -4..+1) = A |
What is the price of ONTO shares?
As of March 15, 2026, the stock is trading at USD 192.74 with a total of 742,877 shares traded.
Over the past week, the price has changed by +5.46%, over one month by -12.75%, over three months by +21.48% and over the past year by +40.74%.
Over the past week, the price has changed by +5.46%, over one month by -12.75%, over three months by +21.48% and over the past year by +40.74%.
Is ONTO a buy, sell or hold?
Onto Innovation has received a consensus analysts rating of 4.11.
Therefore, it is recommended to buy ONTO.
- StrongBuy: 4
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ONTO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 265.7 | 37.9% |
| Analysts Target Price | 265.7 | 37.9% |
ONTO Fundamental Data Overview March 11, 2026
P/E Trailing = 68.9425
P/E Forward = 27.8552
P/S = 9.4761
P/B = 4.2523
P/EG = 0.9288
Revenue TTM = 1.01b USD
EBIT TTM = 153.1m USD
EBITDA TTM = 220.4m USD
Long Term Debt = 17.5m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 5.62m USD (from shortTermDebt, two quarters ago)
Debt = 14.1m USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -625.6m USD (calculated as Total Debt 14.1m - CCE 639.6m)
Enterprise Value = 8.90b USD (9.53b + Debt 14.1m - CCE 639.6m)
Interest Coverage Ratio = -15.63 (Ebit TTM 153.1m / Interest Expense TTM -9.79m)
EV/FCF = 29.69x (Enterprise Value 8.90b / FCF TTM 299.8m)
FCF Yield = 3.37% (FCF TTM 299.8m / Enterprise Value 8.90b)
FCF Margin = 29.82% (FCF TTM 299.8m / Revenue TTM 1.01b)
Net Margin = 13.60% (Net Income TTM 136.8m / Revenue TTM 1.01b)
Gross Margin = 49.72% ((Revenue TTM 1.01b - Cost of Revenue TTM 505.5m) / Revenue TTM)
Gross Margin QoQ = 46.39% (prev 50.70%)
Tobins Q-Ratio = 3.76 (Enterprise Value 8.90b / Total Assets 2.37b)
Interest Expense / Debt = 22.51% (Interest Expense 3.17m / Debt 14.1m)
Taxrate = 46.07% (9.00m / 19.5m)
NOPAT = 82.6m (EBIT 153.1m * (1 - 46.07%))
Current Ratio = 5.79 (Total Current Assets 1.27b / Total Current Liabilities 218.9m)
Debt / Equity = 0.01 (Debt 14.1m / totalStockholderEquity, last quarter 2.10b)
Debt / EBITDA = -2.84 (Net Debt -625.6m / EBITDA 220.4m)
Debt / FCF = -2.09 (Net Debt -625.6m / FCF TTM 299.8m)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.10% (Net Income 136.8m / Total Assets 2.37b)
RoE = 6.85% (Net Income TTM 136.8m / Total Stockholder Equity 2.00b)
RoCE = 7.60% (EBIT 153.1m / Capital Employed (Equity 2.00b + L.T.Debt 17.5m))
RoIC = 4.14% (NOPAT 82.6m / Invested Capital 2.00b)
WACC = 13.57% (E(9.53b)/V(9.54b) * Re(13.57%) + D(14.1m)/V(9.54b) * Rd(22.51%) * (1-Tc(0.46)))
Discount Rate = 13.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.02%
[DCF] Terminal Value 65.28% ; FCFF base≈265.4m ; Y1≈327.4m ; Y5≈557.5m
[DCF] Fair Price = 100.3 (EV 4.36b - Net Debt -625.6m = Equity 4.99b / Shares 49.7m; r=13.57% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -6.83 | EPS CAGR: -1.03% | SUE: 0.0 | # QB: 0
Revenue Correlation: 24.14 | Revenue CAGR: 2.72% | SUE: -0.05 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.52 | Chg7d=+0.124 | Chg30d=+0.124 | Revisions Net=+5 | Analysts=7
EPS current Year (2026-12-31): EPS=6.52 | Chg7d=+0.289 | Chg30d=+0.289 | Revisions Net=+7 | Growth EPS=+31.9% | Growth Revenue=+24.9%
EPS next Year (2027-12-31): EPS=8.18 | Chg7d=+0.497 | Chg30d=+0.497 | Revisions Net=+5 | Growth EPS=+25.5% | Growth Revenue=+15.6%
[Analyst] Revisions Ratio: +0.71 (6 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 12.1% (Discount Rate 13.6% - Earnings Yield 1.5%)
[Growth] Growth Spread = +7.5% (Analyst 19.6% - Implied 12.1%)
P/E Forward = 27.8552
P/S = 9.4761
P/B = 4.2523
P/EG = 0.9288
Revenue TTM = 1.01b USD
EBIT TTM = 153.1m USD
EBITDA TTM = 220.4m USD
Long Term Debt = 17.5m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 5.62m USD (from shortTermDebt, two quarters ago)
Debt = 14.1m USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -625.6m USD (calculated as Total Debt 14.1m - CCE 639.6m)
Enterprise Value = 8.90b USD (9.53b + Debt 14.1m - CCE 639.6m)
Interest Coverage Ratio = -15.63 (Ebit TTM 153.1m / Interest Expense TTM -9.79m)
EV/FCF = 29.69x (Enterprise Value 8.90b / FCF TTM 299.8m)
FCF Yield = 3.37% (FCF TTM 299.8m / Enterprise Value 8.90b)
FCF Margin = 29.82% (FCF TTM 299.8m / Revenue TTM 1.01b)
Net Margin = 13.60% (Net Income TTM 136.8m / Revenue TTM 1.01b)
Gross Margin = 49.72% ((Revenue TTM 1.01b - Cost of Revenue TTM 505.5m) / Revenue TTM)
Gross Margin QoQ = 46.39% (prev 50.70%)
Tobins Q-Ratio = 3.76 (Enterprise Value 8.90b / Total Assets 2.37b)
Interest Expense / Debt = 22.51% (Interest Expense 3.17m / Debt 14.1m)
Taxrate = 46.07% (9.00m / 19.5m)
NOPAT = 82.6m (EBIT 153.1m * (1 - 46.07%))
Current Ratio = 5.79 (Total Current Assets 1.27b / Total Current Liabilities 218.9m)
Debt / Equity = 0.01 (Debt 14.1m / totalStockholderEquity, last quarter 2.10b)
Debt / EBITDA = -2.84 (Net Debt -625.6m / EBITDA 220.4m)
Debt / FCF = -2.09 (Net Debt -625.6m / FCF TTM 299.8m)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.10% (Net Income 136.8m / Total Assets 2.37b)
RoE = 6.85% (Net Income TTM 136.8m / Total Stockholder Equity 2.00b)
RoCE = 7.60% (EBIT 153.1m / Capital Employed (Equity 2.00b + L.T.Debt 17.5m))
RoIC = 4.14% (NOPAT 82.6m / Invested Capital 2.00b)
WACC = 13.57% (E(9.53b)/V(9.54b) * Re(13.57%) + D(14.1m)/V(9.54b) * Rd(22.51%) * (1-Tc(0.46)))
Discount Rate = 13.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.02%
[DCF] Terminal Value 65.28% ; FCFF base≈265.4m ; Y1≈327.4m ; Y5≈557.5m
[DCF] Fair Price = 100.3 (EV 4.36b - Net Debt -625.6m = Equity 4.99b / Shares 49.7m; r=13.57% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -6.83 | EPS CAGR: -1.03% | SUE: 0.0 | # QB: 0
Revenue Correlation: 24.14 | Revenue CAGR: 2.72% | SUE: -0.05 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.52 | Chg7d=+0.124 | Chg30d=+0.124 | Revisions Net=+5 | Analysts=7
EPS current Year (2026-12-31): EPS=6.52 | Chg7d=+0.289 | Chg30d=+0.289 | Revisions Net=+7 | Growth EPS=+31.9% | Growth Revenue=+24.9%
EPS next Year (2027-12-31): EPS=8.18 | Chg7d=+0.497 | Chg30d=+0.497 | Revisions Net=+5 | Growth EPS=+25.5% | Growth Revenue=+15.6%
[Analyst] Revisions Ratio: +0.71 (6 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 12.1% (Discount Rate 13.6% - Earnings Yield 1.5%)
[Growth] Growth Spread = +7.5% (Analyst 19.6% - Implied 12.1%)